- Home
- DNLI vs CNMD Comparison
DNLI vs CNMD Comparison
Compare DNLI & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- CNMD
- Stock Information
- Founded
- DNLI 2013
- CNMD 1970
- Country
- DNLI United States
- CNMD United States
- Employees
- DNLI N/A
- CNMD N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DNLI Health Care
- CNMD Health Care
- Exchange
- DNLI Nasdaq
- CNMD Nasdaq
- Market Cap
- DNLI 1.8B
- CNMD 1.7B
- IPO Year
- DNLI 2017
- CNMD 1987
- Fundamental
- Price
- DNLI $12.74
- CNMD $48.59
- Analyst Decision
- DNLI Strong Buy
- CNMD Buy
- Analyst Count
- DNLI 16
- CNMD 5
- Target Price
- DNLI $37.57
- CNMD $77.20
- AVG Volume (30 Days)
- DNLI 1.7M
- CNMD 536.8K
- Earning Date
- DNLI 05-06-2025
- CNMD 04-30-2025
- Dividend Yield
- DNLI N/A
- CNMD 1.65%
- EPS Growth
- DNLI N/A
- CNMD 108.33
- EPS
- DNLI N/A
- CNMD 4.25
- Revenue
- DNLI N/A
- CNMD $1,307,015,000.00
- Revenue This Year
- DNLI N/A
- CNMD $5.97
- Revenue Next Year
- DNLI $372.05
- CNMD $5.63
- P/E Ratio
- DNLI N/A
- CNMD $11.43
- Revenue Growth
- DNLI N/A
- CNMD 5.00
- 52 Week Low
- DNLI $10.57
- CNMD $47.25
- 52 Week High
- DNLI $33.33
- CNMD $78.58
- Technical
- Relative Strength Index (RSI)
- DNLI 42.15
- CNMD 32.11
- Support Level
- DNLI $12.37
- CNMD $47.25
- Resistance Level
- DNLI $13.63
- CNMD $57.17
- Average True Range (ATR)
- DNLI 1.24
- CNMD 3.25
- MACD
- DNLI 0.23
- CNMD -0.81
- Stochastic Oscillator
- DNLI 50.94
- CNMD 9.65
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.